The company had reported net profit of Rs 128.55 crore in the same quarter a year ago.
GlaxoSmithKline Consumer Healthcare's net sales went up by 17.44% to Rs 971.94 crore in the September 2013 quarter under review as against Rs 827.54 crore in the corresponding period last year, the company said in a BSE filing.
Also Read
GSK Consumer Healthcare's advertising and promotion expenses in the quarter were at Rs 163.24 crore, up 20.40% as against Rs 135.58 crore in the same period last year.
Overall expenses of the company in the quarter were at Rs 833.63 crore, an increase of 19.98% as compared with Rs 694.76 crore in the corresponding period last year.
Shares of GlaxoSmithKline Consumer Healthcare were trading at Rs 4,730 apiece in the afternoon trade, up 1.96% from their previous day's close on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)